Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update

Go back to Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: MIST) Delayed: 1.31 +0.01 (0.77%)
Previous Close $1.30    52 Week High
Open $1.28    52 Week Low
Day High $1.34    P/E N/A 
Day Low $1.27    EPS
Volume 1,771,933